Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$18.0M. SLS currently screens at market cap $1.62B.
Use this SLS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SLS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SLS SEC filings page. Lician reads the product cache first so this HTML stays unique to Sellas Life Sciences Group Inc even when a live quote feed is slow.
Latest cached year on this hub. Full SLS income, balance, and cash tables.